Clinical trial accrual among new cancer patients at a community‐based cancer center
Authors:
- Ronald S. GoRGRonald S. Go
- Jennifer A. LeeJLJennifer A. Lee
- Michelle A. MathiasonMMMichelle A. Mathiason
- Christine M. MeyerCMChristine M. Meyer
- Jonean E. SchroederJSJonean E. Schroeder
- Kathryn E. UmbergerKUKathryn E. Umberger
Open Access
Abstract
BACKGROUND: To the authors' knowledge, only limited data are available regarding clinical trial accrual patterns and the barriers encountered among newly diagnosed patients seen at community‐based cancer centers.METHODS: In the current study, the authors prospectively collected clinical and sociodemographic data from all adult patients seen at a community‐based cancer center who had new cancers diagnosed between 2003–2004. Clinical trial enrollment decisions were noted and factors that prevented accrual were identified.RESULTS: There was a total of 1012 new cancer patients. In 587 patients (58%), clinical trials appropriate for the diagnosis and stage of disease were not available. Among those patients for whom trials were available, 19.8% did not meet eligibility criteria, and only 9.9% of patients were enrolled. Although more trials were found to be available for women compared with men (51% vs. 32%; P < 0.01), the accrual rates were equal (11.2% vs. 7.6%; P = 0.24). Elderly patients comprised approximately 59.4% of those patients with available trials, but they were less likely to be enrolled (5.1% vs. 16.8%; P < 0.01). The major barriers to nonparticipation can be grouped into protocol limitations (68.1%), physician triage (16%), and patient decisions (15.9%). The overall accrual rate when all patients were included was 4% (42 of 1012 patients).CONCLUSIONS: At the study institution, participation in clinical trials is reported to be low. The unavailability of appropriate clinical trials represents the most significant barrier. Continuing efforts to encourage physicians and to educate patients remain necessary. If the current study findings are found to be applicable to other community‐based cancer centers, making a larger variety of clinical trials available to the community may help to improve the accrual of patients to national cancer clinical trials. Cancer 2006. © 2005 American Cancer Society.Keywords
This publication has 45 references indexed in Scilit:
- The impact of socioeconomic status and race on trial participation for older women with breast cancerCancer, 2005
- Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their DecisionJournal of Clinical Oncology, 2004
- Interventions to Improve Research Participants' Understanding in Informed Consent for ResearchJAMA, 2004
- A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the american college of surgeons oncology groupJournal of the American College of Surgeons, 2004
- An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Factors Associated With Breast Cancer Clinical Trials Participation and Enrollment at a Large Academic Medical CenterJournal of Clinical Oncology, 2004
- Clinical trial participation among patients enrolled in the Glioma Outcomes ProjectCancer, 2002
- Sociodemographic and Clinical Predictors of Participation in Two Randomized TrialsControlled Clinical Trials, 2001
- What influences participation in clinical trials in palliative care in a cancer centre?European Journal of Cancer, 2000
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999